MedTrace Logo

An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults

NCT02819310 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2020-07-09

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the safety of chronic use of BLI400 laxative in constipated adults.

Conditions

Interventions

DRUG

BLI400 Laxative

oral laxative

Sponsors & Collaborators

  • Braintree Laboratories

    lead INDUSTRY

Principal Investigators

  • John McGowan · Braintree Laboratories, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02819310 on ClinicalTrials.gov